Celebrating 25 years Est 1999-2024
*Across 3 years $3395.52 only $1697.76
Filed by Renovacor, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549...
false 0001799850 0001799850 2022-09-22 2022-09-22 0001799850 rcor:CommonStockParValue0.0001PerShare2Member 2022-09-22 2022-09-22 0001799850...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________ ...
Filed Pursuant to Rule 424(b)(3) Registration No. 333-260299 Prospectus Supplement...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section...
false 0001799850 0001799850 2022-09-19 2022-09-19 0001799850 us-gaap:CommonStockMember 2022-09-19 2022-09-19 0001799850...
Shares of Renovacor (NYSE: RCOR) were up in early morning trading on Tuesday following the news of its acquisition by Rocket Pharmaceuticals...
The word ‘acquisition’ typically is one of the biggest catalysts for shares of publicly traded companies. Tuesday’s premarket is...
Acquisition further strengthens Rocket’s leadership in AAV-based cardiac gene therapy and expands Company’s near-term clinical assets for the...
Biotech is getting some attention this week as healthcare stocks seem to be outperforming major indices. Just today, a certain Connecticut-based...
E ratio of (3.26).https://www.tipranks.com/news/blurbs/chardan-capital-sticks-to-their-buy-rating-for-renovacor-rcor?utm_source=advfn.com&utm_mediu...
Filed Pursuant to Rule 424(b)(3) Registration No. 333-260299 Prospectus Supplement No. 11...
0001799850false--12-31three yearsQ20001799850us-gaap:MeasurementInputExpectedTermMemberrcor:PrivatePlacementWa...
0001799850false0001799850us-gaap:CommonStockMember2022-08-082022-08-0800017998502022-08-082022-08-080001799850us-gaap:WarrantMember2022-08-082022...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.